Abstract
Pneumatosis intestinalis is a rare but known potential complication of treatment with cetuximab. Here we present two cases of pneumatosis intestinalis occurring in patients who were receiving cetuximab as treatment for advanced head and neck cancer. In both cases, cetuximab was discontinued after discovery of the pneumatosis intestinalis.
Cite
CITATION STYLE
APA
Miller, J. A., Ford, D. J., Ahmed, M. S., & Loree, T. R. (2015). Two Cases of Pneumatosis Intestinalis during Cetuximab Therapy for Advanced Head and Neck Cancer. Case Reports in Oncological Medicine, 2015, 1–3. https://doi.org/10.1155/2015/214236
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free